Loading
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Feb 2026 for Compass Therapeutics, Inc., €203k.
Filing timeline
BuySaleThomas J. Schuetz
Insider track record
Disclosed buys
24
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+7.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Thomas J. Schuetz: trading record in brief
Thomas J. Schuetz, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Compass Therapeutics, Inc., Relypsa Inc and Audentes Therapeutics, Inc. In total, 39 filings cover trades dated from 15 March 2016 to 8 February 2026.
On the market, this insider has only ever bought: 24 purchases, €1.9M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 12 share grants.
In size, the median ticket on the buying side is €47k. Clusters matter here: 7 out of 23 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
On 10 February 2026 came the latest disclosure, a share grant for €203k in Compass Therapeutics, Inc. The latest purchase dates back some time: it was published 515 days ago, on 27 May 2025. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas J. Schuetz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
36,687 shares@ US$6.524.7% of flowCommon StockSEC:0001171843-26-000722:0
46,777 shares@ US$5.355.0% of flowCommon StockSEC:0001171843-26-000205:0
250,000 shares@ US$5.1725.7% of flowCommon StockSEC:0001171843-26-000060:0
44,025 shares@ US$4.836.6% of flowCommon StockSEC:0001171843-25-007400:0
10,000 shares@ US$2.110.4% of flowCommon StockSEC:0001171843-25-003462:0
Canonical exit: 25 Aug 2025 (T+90)
41,687 shares@ US$3.505.4% of flowCommon StockSEC:0001171843-25-000735:0
58,054 shares@ US$1.864.0% of flowCommon StockSEC:0001171843-25-000195:0
44,782 shares@ US$1.452.3% of flowCommon StockSEC:0001171843-24-000714:0
637,500 shares@ US$1.9343.4% of flowCommon StockSEC:0001171843-24-000178:0
44,025 shares@ US$1.502.4% of flowCommon StockSEC:0001171843-23-007222:0
10,000 shares@ US$3.371.2% of flowCommon StockSEC:0001171843-23-001588:0
Canonical exit: 8 Jun 2023 (T+90)
20,000 shares@ US$3.982.9% of flowCommon StockSEC:0001171843-23-001175:0
Canonical exit: 28 May 2023 (T+90)
20,000 shares@ US$3.862.8% of flowCommon StockSEC:0001171843-23-000974:0
Canonical exit: 16 May 2023 (T+90)
500,000 shares0Common StockSEC:0001171843-23-000851:0
20,000 shares@ US$4.052.9% of flowCommon StockSEC:0001171843-23-000557:0
Canonical exit: 1 May 2023 (T+90)
20,000 shares@ US$4.193.0% of flowCommon StockSEC:0001171843-23-000419:0
Canonical exit: 24 Apr 2023 (T+90)
10,000 shares@ US$2.320.9% of flowCommon StockSEC:0001171843-22-006282:0
Canonical exit: 27 Dec 2022 (T+90)
15,000 shares@ US$2.271.4% of flowCommon StockSEC:0001171843-22-006243:0
Canonical exit: 25 Dec 2022 (T+90)
15,000 shares@ US$3.031.8% of flowCommon StockSEC:0001171843-22-006005:0
Canonical exit: 6 Dec 2022 (T+90)
15,000 shares@ US$2.831.6% of flowCommon StockSEC:0001171843-22-005905:0
Canonical exit: 30 Nov 2022 (T+90)
15,000 shares@ US$3.051.7% of flowCommon StockSEC:0001171843-22-005700:0
Canonical exit: 15 Nov 2022 (T+90)
15,000 shares@ US$2.641.5% of flowCommon StockSEC:0001171843-22-005567:0
Canonical exit: 8 Nov 2022 (T+90)
15,000 shares@ US$2.581.5% of flowCommon StockSEC:0001171843-22-005231:0
Canonical exit: 30 Oct 2022 (T+90)
20,000 shares@ US$2.800.016% mcap10.7% of flowCommon StockSEC:0001171843-22-004440:0
Canonical exit: 19 Sept 2022 (T+90)
20,000 shares@ US$2.341.0% of flowCommon StockSEC:0001171843-22-004408:0
Canonical exit: 14 Sept 2022 (T+90)
25 of 33 declarations
